Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q3 2023 · 10-Q
Revenue$54.29M$54.29M−0.7% vs Q3 2022 Net Income$451.00K$451.00KN/M vs Q3 2022 EPS Diluted$0.08$0.08N/M vs Q3 2022 Gross Profit$32,765,000+14.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$7,718,000−51.5% Free Cash Flowderived$6,064,000−56.2% Margins · derivedGross margin60.4%+8.0 pt vs Q3 2022
Operating margin6.3%+10.9 pt vs Q3 2022
Net margin0.8%+4.6 pt vs Q3 2022
ended Dec 31, 2022 · filed Feb 6, 2023 · 37 d after period end